Shares of First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT – Get Free Report) reached a new 52-week high on Monday . The company traded as high as GBX 1,723.20 ($21.04) and last traded at GBX 1,723.20 ($21.04), with a volume of 519 shares. The stock had previously closed at GBX 1,702.60 ($20.79).
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Trading Up 1.2 %
The company has a debt-to-equity ratio of 0.04, a current ratio of 9.42 and a quick ratio of 9.27. The firm has a fifty day simple moving average of GBX 1,650.47 and a 200-day simple moving average of GBX 1,590.06. The firm has a market cap of £5.09 billion and a P/E ratio of -1,566.55.
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Company Profile
Forbidden Technologies plc develops and owns cloud-based video technology in the United Kingdom, North America, and internationally. It offers Forscene, a cloud based video post-production and publishing platform with various applications, such as editing, adding closed caption, graphics, metadata fast, remote viewing, collaboration, and publishing content.
Recommended Stories
- Five stocks we like better than First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- ServiceTitan Made Waves in Its IPO, But Is the Stock a Buy?
- How to Calculate Options Profits
- Netflix: Is This the Perfect Time to Buy a Streaming Powerhouse?
- What Are Dividend Challengers?
- Goldman Sachs Unveils 3 Massive Opportunities for 2025 Investors
Receive News & Ratings for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation and related companies with MarketBeat.com's FREE daily email newsletter.
